Experimental drug leads to remarkable recoveries in 2 prostate cancer patientsJune 20th, 2009 - 3:21 pm ICT by ANI
London, June 20 (ANI): Two patients with inoperable prostate cancer have made remarkable recoveries after being given only a single dose of an experimental drug, called ipilimumab.
Rodger Nelson and Fructuoso Solano-Revuelta were diagnosed with advanced prostate cancer, and were part of a trial at the Mayo Clinic in Minnesota in the US that involved 108 patients, half of whom received the experimental drug.
The drug’s results were so impressive that researchers decided to release details of the two cases before the drug trial was complete.
Dr Eugene Kwon, the urologist who was in charge of their treatment, said that their progress had exceeded all expectations, and likened the results to the first pilot breaking the sound barrier.
“This is one of the Holy Grails of prostate cancer research. We have been looking for this for years,” the Independent quoted him as saying.
Initially, the pair were told that the disease had spread beyond the prostate-Nelson’s cancer was encroaching on the abdomen and Solano-Revuelta’s tumour was the size of a golf ball.
Usually, patients in such condition are told they may have only months to live, and are normally only offered palliative care.
But after one infusion of the drug ipilimumab, a monoclonal antibody that stimulates the immune system, given with conventional hormone therapy, their tumours shrank enough to be surgically removed.
Since then, both men have made a full recovery and returned to their businesses.
Although the trial is still going on, but the improvement of the two patients was so dramatic and unexpected that they were removed from the study so they could undergo curative surgery.
“Halfway through the trial we began seeing remarkable responses. Some patients had dramatic shrinkage of their tumours so practically all traces had disappeared. We had thought we might get some incremental delay in the progression of the cancer. It had not dawned on us that we might go from an inoperable tumour to an operable one. That just doesn’t happen,” said Kwon. (ANI)
- Electric shocks soften up cancer cells for treatment - Dec 07, 2010
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Scientists stumble upon 'stop cancer' gene - Nov 16, 2011
- Skin cancer pill shrinks tumour in 80 percent cases - Aug 26, 2010
- Wonder drug could kill all types of cancer - Jun 27, 2011
- New drugs to kill cancers minus side-effects - May 21, 2012
- Scientists find new way to 'starve' cancer cells - Apr 05, 2011
- Potential cancer drug developed from Australian rainforest plant - Jun 15, 2010
- New drug hope for lung cancer sufferers - Mar 29, 2011
- Skin cancer pill showing 'remarkable' results, say researchers - Aug 26, 2010
- Simple test could save prostate cancer patients from surgery - Feb 09, 2011
- New prostate cancer imaging technique can 'see' tumors grow - Dec 03, 2010
- Experimental drug for advanced prostate cancer shows promise - Apr 15, 2010
- Targeted treatment for prostate cancer to be tested - Apr 17, 2010
- Cancer 'wonder drug' launched in Britain - Sep 21, 2011
Tags: abdomen, breaking the sound barrier, curative surgery, experimental drug, golf ball, holy grails, hormone therapy, immune system, mayo clinic, monoclonal antibody, palliative care, prostate cancer, prostate cancer patients, prostate cancer research, remarkable recoveries, revuelta, shrinkage, tumour, tumours, urologist